Test Directory
| Test Code | |||||
| PERTU | |||||
| Test Name | |||||
| B pertussis Antibodies | |||||
| CPT Codes | |||||
| 86615 X 2 | |||||
| Included Tests | |||||
|
|||||
| Expected Turnaround Time | |||||
| 1 - 5 days | |||||
| Clinical Utility | |||||
|
Establish evidence of infection/exposure to Bordetella pertussis, the causative agent of whooping cough. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain Desired Specimen Volume: 1 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Causes for Rejection | |||||
|
|||||
| Methodology | |||||
| ELISA | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Patients with acute infection develop IgG, IgM, and IgA antibodies to fimbrial agglutinogens, and IgM and IgA antibodies are probably diagnostic. Following vaccination, IgG and IgM antibodies can be demonstrated. IgG antibodies can only be used to diagnose acute infection when paired sera are available and a rise in antibody level can be demonstrated. |
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Varies | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.